Non Serious Adverse Drug Reactions Report

Start Date:2016-04-04 End Date:2016-04-05
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0178Subject Initials :XSCDOB :10/11/1988Sex:FemaleRace:AsianHeight:155cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/10/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal resistance. Uk-Jan-2013Not on treatment/medication
Laparoscopy surgery: pelvic adhesions dissection, bilateral salpingo-repair plastic surgery, normal uterine shape.Uk-Jan-2013Not on treatment/medication
Hysteroscopy normal, water surgery: incomplete right fallopian tube obstructionUk-Feb-2015Not on treatment/medication
 



05-APR-16
NA/EMR700623-541/C02-0178
Page 1 of 9
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-04 End Date:2016-04-05
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0179Subject Initials :HYZDOB :05/14/1991Sex:FemaleRace:AsianHeight:158cmWeight:53.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/11/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy laparotomy: the left fallopian tube removal.Uk-Unk-2009Not on treatment/medication
Abdominal ectopic pregnancy conservative surgery.Uk-Unk-2010Not on treatment/medication
Hysteroscopy: endometrial polyp excision.Uk-Jan-2015Not on treatment/medication
 



05-APR-16
NA/EMR700623-541/C02-0179
Page 2 of 9
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-04 End Date:2016-04-05
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0180Subject Initials :YPWDOB :08/20/1982Sex:FemaleRace:AsianHeight:156cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/13/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy: treatment of chemical drugs to kill embryosUk-Unk-2012Not on treatment/medication
HSG: bilateral tubal occlusionUk-Unk-2008Not on treatment/medication
 



05-APR-16
NA/EMR700623-541/C02-0180
Page 3 of 9
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-04 End Date:2016-04-05
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0185Subject Initials :YMXDOB :09/07/1975Sex:FemaleRace:AsianHeight:159cmWeight:63.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/28/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/15/201506/20/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal occlusion Uk-Unk-2013Not on treatment/medication
 



05-APR-16
NA/EMR700623-541/C02-0185
Page 4 of 9